UPDATED Apr 24, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
YINB2 | €0.90 | 0% | -6.3% | €20.4m | n/a | PE131.2x | n/a | n/a | Real Estate Management and Development | ||
DESA | €12.30 | 0% | n/a | €21.9m | €18.00 | PE10.3x | E16.4% | 6.9% | Capital Goods | ||
DOMO | €1.37 | 0% | -13.8% | €15.5m | n/a | PE3.5x | n/a | 31.9% | Real Estate Management and Development | ||
EBRO | €15.86 | 3.1% | -7.4% | €2.4b | €19.81 | PE13.1x | E2.2% | 4.2% | Food, Beverage & Tobacco | ||
SNG | €3.14 | 3.3% | -18.9% | €165.7m | n/a | PE22.7x | n/a | 1.3% | Software | ||
YZBL | €1.09 | -0.9% | -3.5% | €703.6m | n/a | PB0.9x | n/a | 3.3% | Real Estate | ||
NTH | €1.67 | -0.6% | -3.2% | €100.1m | n/a | PE8.9x | E-2.0% | 6.0% | Retail | ||
ITX | €45.19 | 3.7% | 43.4% | €140.7b | €45.19 | PE26.1x | E7.3% | 3.4% | Retail | ||
VID | €97.40 | 2.2% | 5.1% | €3.1b | €106.62 | PE13.5x | E4.6% | 1.4% | Materials | ||
ENO | €20.80 | 6.9% | 74.1% | €1.8b | €26.73 | PE28.1x | E-22.6% | 2.1% | Capital Goods | ||
IBG | €19.20 | 4.1% | 21.5% | €205.2m | €27.88 | PE4.4x | E-25.2% | 3.4% | Materials | ||
A3M | €4.60 | 4.7% | 26.2% | €1.0b | €4.54 | PE6.1x | E-12.2% | 9.1% | Media | ||
REP | €15.01 | -1.3% | 9.3% | €18.3b | €17.56 | PE5.9x | E-2.8% | 6.7% | Energy | ||
TRH | €1.00 | 0% | 0% | €300.0k | n/a | PE0.4x | n/a | n/a | Consumer Services | ||
YMPI | €0.96 | 0% | -11.1% | €10.8m | n/a | PS11.9x | n/a | 13.3% | Real Estate Management and Development | ||
ALM | €8.39 | 3.5% | -9.4% | €1.8b | €11.28 | PS2x | E47.0% | 2.3% | Pharmaceuticals & Biotech | ||
GSJ | €4.08 | 0.7% | 6.8% | €265.3m | €8.78 | PE13.3x | E11.9% | 3.7% | Capital Goods | ||
COM | €0.61 | -6.9% | -57.9% | €11.1m | €1.00 | PE45.5x | S6.3% | 4.4% | Commercial Services | ||
NEA | €6.96 | 1.2% | 21.0% | €84.6m | €10.00 | PE8x | E8.6% | 3.9% | Capital Goods | ||
CBAV | €28.00 | 0% | 50.9% | €456.5m | n/a | PE12.7x | n/a | 5.6% | Healthcare | ||
MYD | €8.00 | 0% | 0% | €3.9m | n/a | PE0.06x | n/a | 400.0% | Materials | ||
TR1 | €2.88 | 13.4% | 55.3% | €28.1m | €3.20 | PE26.1x | S15.2% | 1.1% | Software | ||
FAE | €3.28 | 4.1% | 3.0% | €1.0b | €3.71 | PE11.1x | E-1.1% | 4.7% | Pharmaceuticals & Biotech | ||
MCM | €11.35 | -0.4% | -4.6% | €433.4m | n/a | PE10.1x | n/a | 3.8% | Materials |